Analog of kenpaullone (Prod. No. BML-EI310) acting as a potent and ATP-competitive inhibitor of GSK-3β (IC50=18nM). Displays ~100-200 fold greater selectivity on GSK-3β than over CDK1/cyclin B and CDK5/p25 (IC50=2.0µM and 4.2µM, respectively).
Product Details
Alternative Name: | 9-Bromo-7,12-dihydropyrido[3',2':2,3]azepino[4,5-b]indol-6(5H)-one, 1-AKP |
|
Formula: | C15H10BrN3O |
|
MW: | 328.2 |
|
CAS: | 676596-65-9 |
|
Purity: | ≥95% (HPLC, TLC) |
|
Appearance: | Off-white to brown powder. |
|
Solubility: | Soluble in DMSO; insoluble in water. |
|
Shipping: | Ambient |
|
Long Term Storage: | -20°C |
|
Use/Stability: | Stock solutions are stable for up to 6 months when stored at -20°C. |
|
Handling: | Protect from moisture. Protect from light. |
|
Regulatory Status: | RUO - Research Use Only |
|
Please mouse over
Product Literature References
A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta: T. Hirota, et al.; PNAS USA
105, 20746 (2008),
Abstract;
Full Text
Novel CDK inhibition profiles of structurally varied 1-aza-9-oxafluorenes: B. Voigt, et al.; Bioorg. Med. Chem. Lett.
15, 823 (2005),
Abstract;
1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta: C. Kunick, et al.; Bioorg. Med. Chem. Lett.
14, 413 (2004),
Abstract;
Related Products